Filter
3464
Filtered Results: 3464
Text search:
adverse
health
effects
Featured
Recommendations
361
New Publications
872
Language
Document type
No document type
1910
Studies & Reports
572
Guidelines
559
Manuals
182
Strategic & Response Plan
103
Fact sheets
59
Training Material
44
Situation Updates
16
Infographics
7
Resource Platforms
6
Brochures
3
Videos
2
App
1
Countries / Regions
India
177
Global
138
Kenya
81
South Africa
77
Western and Central Europe
76
Ethiopia
67
Nepal
61
Nigeria
57
Uganda
54
Latin America and the Carribbean
51
Africa
50
Sierra Leone
42
Tanzania
42
Ghana
41
Zambia
40
Malawi
37
Bangladesh
35
Myanmar / Burma
35
Liberia
34
Philippines
32
Rwanda
27
Ukraine
27
Zimbabwe
23
South–East Asia Region
23
Brazil
21
Cambodia
20
Namibia
20
Eastern Europe
20
Syria
19
Indonesia
19
East and Southern Africa
18
Mozambique
15
Asia
15
USA
14
South Sudan
14
Eswatini/ Swaziland
14
Guinea
13
Botswana
13
West and Central Africa
13
Middle East and North Africa
13
Eastern Europe and Central Asia
12
Germany
11
Lesotho
11
Senegal
10
Congo, Democratic Republic of
10
Russia
10
Thailand
9
Sudan
9
Burkina Faso
8
Western Pacific Region
8
Pakistan
7
Colombia
7
Yemen
7
Venezuela
7
Afghanistan
6
Moldova
6
Jordan
5
Lebanon
5
Mali
4
Haiti
4
Somalia
4
China
4
Angola
4
Sri Lanka
4
Chile
4
Paraguay
4
Laos
4
Cameroon
3
Niger
3
Egypt
3
Benin
3
Argentina
3
Ecuador
3
Madagascar
3
Bhutan
3
Timor Leste/ East Timor
3
Tajikistan
3
Vietnam
3
Guinea-Bissau
2
Iraq
2
Gambia
2
Singapore
2
Central African Republic
2
North Macedonia
2
El Salvador
2
Palestine
2
Kyrgyzstan
2
Georgia
2
United Kingdom
2
Belarus
2
Côte d’Ivoire / Ivory Coast
1
Chad
1
Mauritania
1
Ireland
1
Papua New Guinea
1
Vanuatu
1
Peru
1
Burundi
1
Honduras
1
Greece
1
Guatemala
1
Other region
1
Fiji
1
Solomon Islands
1
Poland
1
North Korea
1
Albania
1
Djibouti
1
Canada
1
Romania
1
Lithuania
1
Iran
1
Australia
1
Kazakhstan
1
North America
1
Turkmenistan
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
1111
Clinical Guidelines
386
Public Health
208
Women & Child Health
200
Key Resources
148
Capacity Building
52
Pharmacy & Technologies
33
Toolboxes
Mental Health
366
COVID-19
289
HIV
224
TB
222
Planetary Health
194
Pharmacy
113
AMR
97
NCDs
97
Caregiver
88
NTDs
86
Rapid Response
84
Conflict
73
Ebola
67
Global Health Education
65
Disability
60
Refugee
57
Natural Hazards
39
Specific Hazards
37
Zika
24
Health Financing Toolbox
18
Cholera
17
Polio
17
Social Ethics
7
Typhoon
2
Induced abortion is permitted in Burkina Faso only to save the life and protect the health of a
pregnant woman, or in cases of rape, incest, and severe fetal impairment. As a result, the vast
majority of women who end unintended pregnancies do so ...
A toolkit for pharmacists.
Emerging data show that medication errors and adverse events cause significant harm to patients’ health and
well-being. It is estimated that the burden of ... events due to medicines is now comparable to that of
widespread diseases, such as malaria or tuberculosis.1 The impacts of medication errors also represent a
burden for health systems, with the annual cost associated with medication errors estimated at USD 42 billion
worldwideharm
Essential obstetric and newborn care
recommended
Essential obstetric and newborn care is designed as a tool to help protect mothers and their children in adverse environments. It is intended for midwives, doctors with obstetrics training, and health...
The third edition, released in 2018, has grown to include a total of 18 chapters, contributed by 20 experts and authors from many countries. The goal remains the same: to educate primary care providers on the best practices in TB diagnosis, treatment and follow-up. All articles are richly illustrate...
Briefing Note 8.
Ecosystem-based adaptation (EbA) is a strategy for adapting to the adverse impacts of climate change by harnessing nature and the services it can provide. This strategy is crucial for cities and peri-urban areas, threatened by a mu...
There is increasing interest in understanding the role of air pollution as one of the greatest threats to human health worldwide. Nine of 10 individuals breathe air with polluted compounds that have a great impact on lung tissue. The nature of the r...
"Helping Traumatized Children Learn is the result of an extraordinary collaboration among educators, parents, mental health professionals, community groups, and attorneys determined to help children experiencing the traumatic ... of exposure to family violence succeed in school."
People on the move – migrants, refugees, asylum seekers and other displaced populations – face extraordinary risks to their lives, safety, dignity, human rights and well-being.
In part this is connected to the core reasons that lead to migration and displacement, ranging from violence, persec...
Buruli ulcer caused by Mycobacterium ulcerans is a neglected tropical disease characterized by extensive ulceration involving predominantly the upper and lower limbs of patients. The disease is common in rural tropical communities in West and Central Africa, where access to proper ... care is limited. Pathogenesis of the characteristic painless ulcers is linked to the elaboration by M. ulcerans of a lipid toxin called mycolactone that has potent cytopathic, immunosuppressive, and analgesic effects on a host of cells in cutaneous tissues. Mycolactone is known to profoundly inhibit secretion of a plethora of proteins that are essential for wound healing. Even though a combination antibacterial therapy of streptomycin and rifampicin for 8 weeks is effective for treatment, it relies on good and appropriate wound management to prevent secondary bacterial infections and improve healing. Evidence-based interventions for wound care in Buruli ulcer disease are often lacking and have relied on expert advice and recommendations. Surgical interventions are limited to debridement of necrotic tissue and grafting of extensive ulcers, usually after antibiotic therapy. Patients’ rehabilitation is an important component of care to reduce disabilities associated with the disease and proper integration into the community after treatment.
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initiative was to improve reporting of ... events (AEs) by strengthening passive safety
surveillance via PV training and mentoring of local PV stakeholders and healthcare providers (HCPs) at their own healthcare
facilities (HCFs).
Methods An 18-month PV training and mentoring programme was implemented in collaboration with national stakeholders,
and in partnership with the Ministry of Health, GSK and PATH. Two-day training was provided to Expanded Programme on
Immunisation coordinators, identified as responsible for AE reporting, and four National Regulatory Authority representa-
tives. Abridged PV training and mentoring were provided regularly to HCPs. Support was given in upgrading the national
PV system. Key performance indicators included the number of AEs reported, transmission of AE forms, completeness of
reports, serious AEs reported and timeliness of recording into VigiFlow.
Results In 18 months, 443 HCPs at 61 HCFs were trained. The number of reported AEs increased from 22 (January 2000 to
October 2016) to 228 (November 2016 to May 2018), enabling Malawi to become a member of the World Health Organization
Programme for International Drug Monitoring. Most (98%) AE report forms contained mandatory information on reporter,
event, patient and product, but under 1% were transmitted to the national PV office within 48 h.
Conclusion Regular PV training and mentoring of HCPs were effective in enhancing passive safety surveillance in Malawi,
but the transmission of reports to the national PV centre requires further improvement.
WHO's Health in the Green Economy sector briefings examine the health impacts of climate change mitigation strategies considered by the Intergovernmental Panel on Climate Change in their Fourth Asse...
Summary of the main report: Direct and indirect effects of COVID-19 pandemic and response in South Asia .
It uses a series of exercises based on actual observed changes in services and intervention coverage to model impacts on mortality, hospita...
DRUGS REGULATORY UNIT | NOVEMBER 2009 | SECOND EDITION
7 April 2021
Based on current information, a causal relationship between the vaccine and the occurrence of blood clots with low platelets is considered plausible but is not confirmed.
Available in Englisch, French and Russian
interim guidance, 19 July 2021 (arabic version)
29 September 2021
10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vecto...
DHS Working Papers No. 94 - This study described the family planning initiatives in Rwanda and analyzed the 2005 and 2010 RDHS data to identify factors that contribute to the increase in contraceptive use. The Blinder-Oaxaca technique was used to decompose the contributions of women’s characterist...
